The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo

Clinical Immunology : the Official Journal of the Clinical Immunology Society
J A Tye-DinRevati Shreeniwas

Abstract

Effective treatment of celiac disease is an unmet medical need. A glutenase that destroys immunogenic gluten peptides may be clinically valuable. Twenty patients with celiac disease were randomly assigned to ingest a large gluten meal (16 g daily for 3 days) pre-treated with ALV003, a mixture of highly specific glutenases (n=10), or pre-treated with placebo (n=10). Peripheral blood T-cell IFN-gamma ELISpot responses to gliadin and an immunogenic 33mer and symptoms were assessed. While baseline IFN-gamma ELISpot responses to gliadin and the 33mer were negative in all patients, a significant ELISpot response to gliadin or the 33mer was observed in 6 of 10 patients consuming placebo-treated gluten and 0 of 10 consuming ALV003 pre-treated gluten (p=0.011). Symptoms typically associated with gluten ingestion occurred in both groups and were not significantly reduced by ALV003 pre-treatment. ALV003 pre-treatment can abolish immune responses induced by gluten in patients with celiac disease.

References

Feb 25, 1983·Journal of Immunological Methods·J D Sedgwick, P G Holt
Dec 16, 1983·Journal of Immunological Methods·C C CzerkinskyA Tarkowski
Sep 5, 2002·Nature Reviews. Immunology·Ludvig M Sollid
Sep 28, 2002·Science·Lu ShanChaitan Khosla
May 3, 2003·Methods : a Companion to Methods in Enzymology·Donald D Anthony, Paul V Lehmann
Jun 4, 2005·Clinical and Experimental Immunology·R CiccocioppoG R Corazza
Jul 29, 2005·Immunological Reviews·Bana JabriPeter H R Green
Oct 7, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Gail G PyleGary M Gray
Jun 24, 2006·Chemistry & Biology·Matthew SiegelChaitan Khosla
Feb 20, 2007·Proceedings of the National Academy of Sciences of the United States of America·Melinda RákiLudvig M Sollid
Apr 24, 2007·Histopathology·M T BardellaV Villanacci
Apr 25, 2007·Alimentary Pharmacology & Therapeutics·K KaukinenP Collin
Sep 19, 2008·Current Gastroenterology Reports·Jason Tye-Din, Robert Anderson
Dec 17, 2008·Mucosal Immunology·L M Sollid, K E A Lundin

❮ Previous
Next ❯

Citations

Jun 8, 2012·Seminars in Immunopathology·Christopher S McAllister, Martin F Kagnoff
May 18, 2011·Proceedings of the National Academy of Sciences of the United States of America·Gregor Fuhrmann, Jean-Christophe Leroux
Mar 20, 2013·PloS One·Gregory J TannerCrispin A Howitt
Nov 17, 2012·World Journal of Gastroenterology : WJG·Naiyana GujralAlan B R Thomson
Aug 7, 2013·Nature Reviews. Gastroenterology & Hepatology·Katri KaukinenMarkku Mäki
Nov 5, 2013·Pharmaceutical Research·Gregor Fuhrmann, Jean-Christophe Leroux
Feb 19, 2011·BMC Biotechnology·Tingsu ChenOlof Olsson
Sep 29, 2011·Digestive Diseases and Sciences·Matthew SiegelDaniel C Adelman
Jul 18, 2015·Nutrients·Itziar ChurrucaEdurne Simon
Sep 16, 2014·Expert Opinion on Emerging Drugs·Peter D MooneyDavid S Sanders
Dec 17, 2014·Expert Opinion on Emerging Drugs·Hugh James Freeman
Jan 9, 2013·Expert Opinion on Drug Discovery·Samantha StovenEric V Marietta
May 9, 2014·Expert Opinion on Investigational Drugs·Kalle KurppaKatri Lindfors
Oct 16, 2012·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·J C Vitoria, J R Bilbao
Oct 23, 2012·Gastrointestinal Endoscopy Clinics of North America·Rupa MukherjeeDetlef Schuppan
Jun 26, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Samantha StovenEric Marietta
Dec 30, 2015·Critical Reviews in Food Science and Nutrition·David C DallasJ Bruce German
Sep 29, 2015·Current Opinion in Pharmacology·Justin L McCarvilleElena F Verdu
Jul 11, 2012·Clinical and Experimental Immunology·A CamarcaC Gianfrani
Jun 11, 2015·Best Practice & Research. Clinical Gastroenterology·Nicholas M Plugis, Chaitan Khosla
Jul 26, 2013·Immunological Investigations·Gabriel SamaşcaIulia Lupan
May 25, 2012·Expert Opinion on Therapeutic Targets·Katri LindforsKatri Kaukinen
Jul 2, 2011·Expert Opinion on Pharmacotherapy·Suzanne C DonnellyPaul J Ciclitira
Mar 18, 2015·Critical Reviews in Food Science and Nutrition·I D Bruins SlotR J Hamer
Oct 19, 2014·Gastroenterology Report·Natalia E CastilloDaniel A Leffler
Jun 21, 2016·Expert Review of Clinical Pharmacology·Satya KuradaDaniel A Leffler
Aug 3, 2016·Scientific Reports·Martial ReyDavid C Schriemer
Mar 4, 2014·Gastroenterology·Marja-Leena LähdeahoMarkku Mäki
Apr 14, 2017·Drug Development and Industrial Pharmacy·Giovanna PitarresiGaetano Giammona
Sep 5, 2013·Therapeutic Advances in Gastroenterology·Christina A TennysonPeter H R Green
Jun 2, 2017·Therapeutic Advances in Gastroenterology·Suneeta KrishnareddyPeter Hr Green
Apr 17, 2013·The American Journal of Gastroenterology·Margit BrottveitKnut E A Lundin
Sep 30, 2010·The American Journal of Gastroenterology·Maud PinierJean-Christophe Leroux
Mar 3, 2011·The American Journal of Gastroenterology·Margit BrottveitKnut E A Lundin
Mar 10, 2010·Nature Reviews. Gastroenterology & Hepatology·Greetje J TackChris J J Mulder

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Internal Medicine
Ludvig M Sollid, Chaitan Khosla
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
Gail G PyleGary M Gray
The Journal of Pharmacology and Experimental Therapeutics
Jonathan GassChaitan Khosla
© 2022 Meta ULC. All rights reserved